🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a modular study of AZD2014 in combination with novel anti-cancer ag...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-06
Trial ID
NCT02780830
This is a phase I/II study to evaluate the feasibility, safety and prelimin...
Status
Active Not Recruiting
Location
University of California LA
Start Date
2019-06-26
Trial ID
NCT03960840
Treatments Being Tested
This is a phase 2, open-label, multicenter study evaluating the efficacy an...
Status
Not Yet Recruiting
Location
Institut Jules Bordet
Start Date
2026-12-31
Trial ID
NCT07738887
Treatments Being Tested
Background: Chronic lymphocytic leukemia (CLL) and small lymphocytic lymph...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2020-07-31
Trial ID
NCT04209621
This is a multi-center, open-label study to evaluate the safety, pharmacoki...
Status
Recruiting
Location
St. Joseph's Hospital and Medical Center
Start Date
2017-12-28
Trial ID
NCT03328078
Treatments Being Tested
Phase 2, two cohort trial evaluating the addition of ublituximab and umbral...
Status
Terminated
Location
TG Therapeutics Investigational Trial Site
Start Date
2019-08-05
Trial ID
NCT04016805
Treatments Being Tested
The purpose of this study is to assess the effect of a moderate Cytochrome ...
Status
Completed
Location
Multiple Locations
Start Date
2015-05-19
Trial ID
NCT02381080
Treatments Being Tested
A multi-center, open-label, phase Ib study to evaluate the safety and toler...
Status
Terminated
Location
H Lee Moffitt Cancer Center and Research Institute
Start Date
2019-06-11
Trial ID
NCT03876028
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Terminated
Location
University of Arizona Cancer Center, Tucson
Start Date
2017-03-05
Trial ID
NCT02954406
Treatments Being Tested
Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects with Chron...
Status
Completed
Location
City of Hope
Start Date
2018-11-19
Trial ID
NCT03790332
Treatments Being Tested